I chose to work in cancer care, because cancer is a major cause of morbidity and mortality, in addition to the tremendous cost and suffering to the society.
During the early development phase of the magnetic resonance (MR) contrast agents, I designed and conducted many clinical trials and facilitated the FDA approval of MR contrast agents, which have become essential components of current MR imaging examination. My recent research focuses on assessing tumor heterogeneity for early prediction of ultimate treatment outcomes for cancer and for the collateral circulation status for triaging therapy for acute stroke.
In my lifetime, I hope to see improvements in early diagnosis and early prediction of treatment failure to provide a window of opportunity to change treatment strategy. Additionally, I hope to see improvement to imaging-guided therapy and its ultimate treatment outcome.
Outside of work, I enjoy traveling to see the world and its people.
University of Alabama, Tuscaloosa
Lloyd Noland Hospital, Wadsworth General Veterans Administration Facility
University of Iowa Hospitals & Clinics, Neuroradiology; Harbor-UCLA Medical Center-MRI/CT Scan; Wadsworth General Veterans Administration Facility-Nuclear Medicine
Nuclear Medicine, 1987, American Board of Nuclear Medicine; Diagnostic Radiology, 1985, American Board of Radiology
At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.